CANCER OF THE CERVIX

Clinical trials for CANCER OF THE CERVIX explained in plain language.

Never miss a new study

Get alerted when new CANCER OF THE CERVIX trials appear

Sign up with your email to follow new studies for CANCER OF THE CERVIX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 2

New drug combo aims to slow advanced cervical cancer

Disease control Not yet recruiting

This study tests whether adding a drug called telaglenastat (CB-839) to standard chemoradiation can help people with advanced cervical cancer live longer without the disease getting worse. About 42 adults with stage III-IVA cervical cancer will receive the combination treatment. …

Matched conditions: CANCER OF THE CERVIX

Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated May 17, 2026 08:20 UTC

CANCER OF THE CERVIX

Get alerted when new CANCER OF THE CERVIX trials appear

New drug combo aims to slow advanced cervical cancer